Atria Investments Inc Acquires 1,707 Shares of Danaher Corporation $DHR

Atria Investments Inc raised its holdings in shares of Danaher Corporation (NYSE:DHR) by 5.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 32,863 shares of the conglomerate’s stock after purchasing an additional 1,707 shares during the period. Atria Investments Inc’s holdings in Danaher were worth $6,492,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of DHR. Pacific Capital Partners Ltd bought a new position in Danaher during the 1st quarter valued at approximately $7,175,000. Koshinski Asset Management Inc. raised its position in shares of Danaher by 18.2% in the 1st quarter. Koshinski Asset Management Inc. now owns 1,738 shares of the conglomerate’s stock worth $356,000 after acquiring an additional 267 shares in the last quarter. Clear Creek Financial Management LLC bought a new position in shares of Danaher in the 1st quarter worth approximately $262,000. First Horizon Advisors Inc. raised its position in shares of Danaher by 7.7% in the 1st quarter. First Horizon Advisors Inc. now owns 5,294 shares of the conglomerate’s stock worth $1,085,000 after acquiring an additional 380 shares in the last quarter. Finally, Mutual Advisors LLC raised its position in shares of Danaher by 49.6% in the 1st quarter. Mutual Advisors LLC now owns 9,409 shares of the conglomerate’s stock worth $1,855,000 after acquiring an additional 3,121 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

DHR has been the subject of several research reports. Cowen reissued a “buy” rating on shares of Danaher in a research report on Wednesday, October 22nd. Wall Street Zen lowered Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, October 25th. Deutsche Bank Aktiengesellschaft raised their price objective on Danaher from $235.00 to $250.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Redburn Partners set a $220.00 price objective on Danaher in a research report on Wednesday, October 8th. Finally, Scotiabank raised Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective for the company in a research report on Friday, July 11th. Eighteen investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $243.39.

Danaher Stock Performance

Shares of DHR opened at $215.63 on Friday. The business’s fifty day simple moving average is $203.41 and its two-hundred day simple moving average is $199.47. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $258.23. The company has a market cap of $152.31 billion, a price-to-earnings ratio of 44.46, a P/E/G ratio of 3.28 and a beta of 0.77.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. During the same period last year, the business posted $1.71 EPS. The company’s revenue was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Research analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, October 31st. Shareholders of record on Friday, September 26th were paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date was Friday, September 26th. Danaher’s dividend payout ratio (DPR) is currently 26.39%.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.